Arrowhead Pharmaceuticals Inc Dividends

The next dividend date for Arrowhead Pharmaceuticals Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Arrowhead Pharmaceuticals Inc (ARWR)

No results.

More About Arrowhead Pharmaceuticals Inc

Country
USA
Full Time Employees
711

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Owning Arrowhead Pharmaceuticals Inc Stock on the Dividend Date

If you own Arrowhead Pharmaceuticals Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Arrowhead Pharmaceuticals Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Arrowhead Pharmaceuticals Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Arrowhead Pharmaceuticals Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Arrowhead Pharmaceuticals Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Arrowhead Pharmaceuticals Inc Dividends

You can contact us any time if you would like to ask questions about Arrowhead Pharmaceuticals Inc dividends or anything else related to the stock market.